Technavio analyzes the market by Drug class (NSAIDs, Urate-lowering agents, Corticosteroids, and Colchicine) and Geography (North America, Europe, Asia, and ROW). The increasing number of clinical trials for gout therapeutics is expected to have a positive impact on the growth of the gout therapeutics market during the forecast period.
This study identifies technological advancements in medical imaging as one of the prime reasons driving the gout therapeutics market growth during the next few years.
This report presents a detailed picture of the gout therapeutics market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
The gout therapeutics market covers the following areas:
Gout Therapeutics Market Sizing
Gout Therapeutics Market Forecast
Gout Therapeutics Market Analysis
Companies Mentioned
- AstraZeneca Plc
- Avion Pharmaceuticals LLC
- Cadila Healthcare Ltd.
- Hikma Pharmaceuticals Plc
- Horizon Therapeutics Plc
- Ironwood Pharmaceuticals Inc.
- JW Pharmaceutical Corp.
- Selecta Biosciences Inc.
- Takeda Pharmaceutical Co. Ltd.
- Teijin Ltd.
Subscribe to our "Lite Plan" billed annually at USD 3000 to join a community, who are eligible to view 3 reports monthly and download 3 reports annually.
Related Reports:
Global Human Microbiome Therapeutics Market - Global human microbiome therapeutics market is segmented by Application (Gastrointestinal disorders, Infectious diseases, and Others) and Geography (North America, Europe, Asia, and ROW).
Download Exclusive Free Sample Report
Global Human Combination Vaccines Market - Global human combination vaccines market is segmented by type (inactivated vaccine and live attenuated vaccine) and geography (North America, Europe, Asia, and ROW).
Download Exclusive Free Sample Report
Gout Therapeutics Market Scope |
Report Coverage |
Details |
Page number |
120 |
Base year |
2020 |
Forecast period |
2021-2025 |
Growth momentum & CAGR |
Accelerate at a CAGR of over 14% |
Market growth 2021-2025 |
USD 2.69 billion |
Market structure |
Fragmented |
YoY growth (%) |
13.81 |
Regional analysis |
North America, Europe, Asia, and ROW |
Performing market contribution |
North America at 43% |
Key consumer countries |
US, UK, Germany, Japan, and China |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
AstraZeneca Plc, Avion Pharmaceuticals LLC, Cadila Healthcare Ltd., Hikma Pharmaceuticals Plc, Horizon Therapeutics Plc, Ironwood Pharmaceuticals Inc., JW Pharmaceutical Corp., Selecta Biosciences Inc., Takeda Pharmaceutical Co. Ltd., and Teijin Ltd. |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Related Links
http://www.technavio.com/
Share this article